the safety Medications for Hyperhomocysteinemia with courtesy

damaging Medications for Hyperhomocysteinemia guidelines
 
Photo :Medications for Hyperhomocysteinemia

all over again Medications for Hyperhomocysteinemia Other names: Hyperhomocystenemia Medication List Q & A More What is Hyperhomocysteinemia: Hyperhomocysteinemia is a medical condition characterized by an abnormally large level of homocysteine in the blood. Medications to treat Hyperhomocysteinemia The following list of medications are in some way related to, or used in the treatment of this condition. Drug Class (show all) - vitamins (2) - vitamin and mineral combinations (15) Rx OTC Off Label Only Generics Drug name Rx / OTC Preg nancy CSA Alcohol Reviews Rating Popularity l-methylfolate Rx N N Add review Rate Generic name: l-methylfolate systemic Brand name: Deplin Drug class: vitamins For consumers: dosage , side effects Folbic Rx/OTC N N Add review Rate Generic name: multivitamin systemic Drug class: vitamin and mineral combinations For consumers: interactions , side effects Deplin Rx N N Add review Rate Generic name: l-methylfolate systemic Drug class: vitamins For consumers: dosage , side effects multivitamin Rx/OTC N N 1 review Rate Generic name: multivitamin systemic Brand names: Folbic, Folic Acid XTRA, Folbee, Renal Caps, Folplex 2.2, Folgard RX, Foltrate, Nephrocaps QT, Folcaps, Foltabs 800, Apetex, Apetigen, MTX Support, Vita-Respa Drug class: vitamin and mineral combinations For consumers: interactions , side effects For professionals: A-Z Drug Facts , Prescribing Information Folic Acid XTRA Rx/OTC N N Add review Rate Generic name: multivitamin systemic Drug class: vitamin and mineral combinations For consumers: interactions , side effects Folbee Rx/OTC N N Add review Rate Generic name: multivitamin systemic Drug class: vitamin and mineral combinations For consumers: interactions , side effects Renal Caps Rx/OTC N N Add review Rate Generic name: multivitamin systemic Drug class: vitamin and mineral combinations For consumers: dosage , interactions , side effects For professionals: Prescribing Information Folplex 2.2 Rx/OTC N N Add review Rate Generic name: multivitamin systemic Drug class: vitamin and mineral combinations For consumers: dosage , interactions , side effects Folgard RX Rx/OTC N N Add review Rate Generic name: multivitamin systemic Drug class: vitamin and mineral combinations For consumers: interactions , side effects Foltrate Rx/OTC N N Add review Rate Generic name: multivitamin systemic Drug class: vitamin and mineral combinations For consumers: interactions , side effects Nephrocaps QT Rx/OTC N N Add review Rate Generic name: multivitamin systemic Drug class: vitamin and mineral combinations For consumers: dosage , interactions , side effects For professionals: Prescribing Information Folcaps Rx/OTC N N Add review Rate Generic name: multivitamin systemic Drug class: vitamin and mineral combinations For consumers: dosage , interactions , side effects For professionals: Prescribing Information Foltabs 800 Rx/OTC N N Add review Rate Generic name: multivitamin systemic Drug class: vitamin and mineral combinations For consumers: dosage , interactions , side effects Apetex Rx/OTC N N Add review Rate Generic name: multivitamin systemic Drug class: vitamin and mineral combinations For consumers: interactions , side effects Apetigen Rx/OTC N N Add review Rate Generic name: multivitamin systemic Drug class: vitamin and mineral combinations For consumers: interactions , side effects MTX Support Rx/OTC N N Add review Rate Generic name: multivitamin systemic Drug class: vitamin and mineral combinations For consumers: interactions , side effects Vita-Respa Rx/OTC N N Add review Rate Generic name: multivitamin systemic Drug class: vitamin and mineral combinations For consumers: interactions , side effects Legend Off Label This medication may not be approved by the FDA for the treatment of this condition. Prescription Only / Over the Counter Rx Prescription Only OTC Over the Counter Rx/OTC Prescription or Over the Counter Pregnancy A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters). B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women. C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits. N FDA has not classified the drug. Controlled Substances Act Schedule N Is not subject to the Controlled Substances Act. 1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision. 2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. 3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. 4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. 5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4. Alcohol X Interacts with Alcohol. Browse Drugs by Condition A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Help and Support Looking for answers? Ask a question or go join the hyperhomocysteinemia support group to connect with others who have similar interests. adequate


recommendations Medications for Hyperhomocysteinemia regular


EmoticonEmoticon